Question · Q3 2026
Andrew Gardiner inquired about the expected trajectory of OpEx, particularly R&D investment, into fiscal 2027, and whether its growth rate would slow relative to revenue.
Answer
Jason Child, Arm's Chief Financial Officer, expects the Q4 to Q1 OpEx step-up to be similar to last year's low double-digit sequential growth. He anticipates R&D growth to moderate after Q1 next year compared to the more significant step-ups observed in the current fiscal year.
Ask follow-up questions
Fintool can predict
ARM's earnings beat/miss a week before the call


